Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events Sodium restriction still holds its ground in SODIUM-HF trial Apr 02, 2022
Tranexamic Acid Cuts Surgical Bleeding in Yet Another Setting But POISE-3 trial leaves open the question of cardiovascular safety Apr 02, 2022
From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classes Update also adds SGLT2 inhibitor as a pillar of therapy Apr 01, 2022
In-Person ACC Meeting Returns, Serving Diet Intervention Studies and More Will salt restriction finally get a boost at this weekend's meeting? Mar 31, 2022
Xarelto Flops for COVID-19 Clot Prevention Outside ICU ACTION trial adds nuance to the story from large platform trials May 19, 2021
Burnout in Cardiology; Restrictive Transfusion Foiled; and Other News From ACC Highlights from the scientific program of the American College of Cardiology meeting May 18, 2021
Setbacks for Invasive Strategy, Moderate Cooling in Cardiac Arrest Prague OHCA study, CAPITAL CHILL give some answers for out-of-hospital cardiac arrest treatment May 18, 2021
Falling Through the Cracks on Rapid Troponin Testing Protocols Studies point to potential risks and pitfalls with change to more sensitive, rapid testing May 18, 2021
Novel Heart Failure Agent Works Best in Sickest Patients Omecamtiv mecarbil provides benefit to those with low LVEF May 18, 2021
Plavix Beats Aspirin, Brilinta After Stenting HOST-EXAM and TALOS-AMI studies from South Korea focus on aspects of DAPT May 18, 2021
Finerenone May Delay AFib Onset in Patients With CKD and Diabetes Risk of kidney or CV events reduced regardless of atrial fibrillation or atrial flutter history May 18, 2021
Entresto Risky for Advanced Heart Failure? LIFE trial "not only disappointed but surprised" with its findings May 17, 2021
Stubborn Gaps in Heart Failure Persist Despite Clinician Education, Feedback Guideline-directed medical therapy underuse still a problem in CONNECT-HF trial May 17, 2021
Personalized Rehab Helpful in Heart Failure Patients Trial showed improvements in physical functioning and quality of life compared with usual care May 17, 2021
DARE-19 Didn't Pay Off for Farxiga in COVID-19 But trial may still show SGLT2 inhibitor is safe for sicker patients May 17, 2021
Renal Denervation Shows Worth in Resistant Hypertension Catheter-based procedure gets a win in RADIANCE-HTN TRIO May 16, 2021
A Call for Nuance in Cardioprotection With Early Breast Cancer Therapy Longer-term PRADA trial results weigh in for low-risk group May 16, 2021
FFR Disappoints as Guide for PCI on Non-Culprit Lesions in STEMI Angiography-guided strategy holds strong in FLOWER-MI trial May 16, 2021
LAA Occlusion During Surgery Cuts Stroke Risk Afib patients on antithrombotic therapy saw gains from add-on left atrial appendage occlusion May 16, 2021
Baby Aspirin on Par With Full Dose to Prevent Repeat Heart Events But landmark trial was hampered by crossover May 15, 2021
Strategy of DOAC After TAVR Disappoints in ATLANTIS Is aspirin alone still best after transcatheter aortic valve replacement? May 15, 2021
Mixed Results with ARNI Therapy for Post-MI Heart Failure Prevention Sacubitril/valsartan deemed safe, but still can't beat ramipril in PARADISE-MI trial May 15, 2021
Mavacamten Boosts Quality of Life in Hypertrophic Cardiomyopathy Secondary findings show big gains for more than a third of patients May 15, 2021
ARNI Therapy in the Hot Seat at Another Virtual ACC PARADISE-MI to provide data on Entresto for MI survivors with reduced LVEF May 14, 2021
ISCHEMIA Trial Puts Big Question Mark on Implications of Ischemia Subanalyses of the landmark trial show lack of correlation to outcomes Apr 01, 2020
Mavacamten Promising in Non-Obstructive HCM Phase II MAVERICK-HCM trial looked at safety, efficacy of myosin inhibitor Apr 01, 2020
DAPT Plus DOAC a Loser After Lower Limb Revascularization Three drugs post-procedure is one too many, study suggests Apr 01, 2020
Homozygous FH Falls to Praluent, Novel Agent Drugs succeed in cutting LDL in extra-refractory form of high cholesterol Mar 31, 2020
Higher On-Tx EPA Levels Explain Benefit of Vascepa Further evidence from REDUCE-IT that triglyceride lowering is not key to icosapent ethyl's effects Mar 30, 2020
TWILIGHT Findings Hold Strong in Diabetes, Complex PCI Ticagrelor monotherapy after brief DAPT also worked following newer-gen stent implantation Mar 30, 2020
DOAC Works in Cancer-Related VTE, No Tradeoff in Bleeds Apixaban monotherapy matches dalteparin in non-inferiority trial Mar 29, 2020
More 'Convincing' Data on BP Drop After Renal Denervation Full results reported from SPYRAL HTN-OFF MED Mar 29, 2020
TAVR: Promising in Low-Risk Patients With Bicuspid Anatomy However, pacemaker rate still high in experienced hands, according to early data Mar 29, 2020
AFib Patients Better Off With No Antiplatelet After TAVR POPular TAVI trial supports sticking to anticoagulation alone Mar 29, 2020
Favorable Results for DOAC After Peripheral Intervention But the devil's in the details of the VOYAGER PAD trial, expert opines Mar 28, 2020
Radial vs Femoral; P2Y12 Inhibitor Monotherapy; PCI With Microbubbles Advances in interventional cardiology at ACC 2019 Mar 20, 2019
Bempedoic Acid: Modest LDL Lowering Affirmed CLEAR Wisdom completes the phase III picture; next step, FDA review Mar 20, 2019
